Articles Tagged With: vaccine
-
FDA Struggles to Find Way Forward on COVID-19 Vaccine
Vaccine advisors to the Food and Drug Administration face a tight timeline and a host of unknowns as they try to prepare for an expected winter surge of COVID-19, all the while acknowledging that any plan forward could be dashed by the emergence of a new variant of the pandemic virus.
-
COVID-19 Vaccine Protects Mothers, Newborns
COVID-19 vaccination and pregnancy issues have been clouded by misinformation, leading women who are pregnant or trying to become pregnant to decline immunization. The accumulating evidence strongly suggests not only does vaccination safeguard pregnant women against severe infection, it confers protective immunity to the newborn baby.
-
Booster Doses Effective Against Omicron
While vaccination provides protection against infection with omicron variant of SARS-CoV-2, high level protection from a need for hospitalization requires a booster dose.
-
Urgent Need for ‘Universal’ Vaccines for SARS-CoV-2
There is an emerging consensus in the scientific community that is two-fold: COVID-19 is not going away anytime soon, and continuous vaccine boosters eventually could yield diminishing returns. What is needed are new, second-generation vaccines that confer broader immunity against both circulating variants and mutations yet to arise.
-
Multiple Sclerosis and Immune Response to COVID-19 Vaccination
A large group of patients with multiple sclerosis taking various disease-modifying therapies did not respond uniformly to COVID-19 vaccination.
-
New Research Highlights Effect of COVID-19 on Contraceptive Care
The COVID-19 pandemic caused disruptions and barriers to contraceptive care in its first year. Reproductive health providers have navigated conflicting and confusing messages about vaccine mandates. -
In Addition to Vaccination, Can More Be Done to Prevent Severe COVID-19?
Using data for more than 1.2 million Americans who completed primary vaccination against COVID-19, severe disease outcomes were rare; however, vaccinated persons aged ≥ 65 years with immunosuppression or other underlying conditions were found to be at higher risk.
-
Optimism for New Interventions to Prevent Respiratory Syncytial Virus Infections
Previous vaccines for respiratory syncytial virus infection in children caused more harm than good. However, new vaccines and preventive monoclonal antibody treatments are nearing final stages of prelicensure testing.
-
COVID-19 Vaccination Prevents Systemic Inflammatory Syndrome (MIS-C)
The estimated effectiveness of two doses of Pfizer-BioNTech vaccine in the prevention of multisystem inflammatory syndrome in children was 91%.
-
Vaccines Saved 1 Million Lives in 2021
COVID-19 vaccines prevented an estimated 1 million deaths and 10 million hospitalizations in the United States in 2021, according to a new modeling study by the Commonwealth Fund.